Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Is there a CSF biomarker profile related to depression in elderly women?

Gudmundsson P, Skoog I, Waern M, Blennow K, Zetterberg H, Rosengren L, Gustafson D.

Psychiatry Res. 2010 Apr 30;176(2-3):174-8. doi: 10.1016/j.psychres.2008.11.012. Epub 2010 Feb 4.

PMID:
20132991
2.

The relationship between cerebrospinal fluid biomarkers and depression in elderly women.

Gudmundsson P, Skoog I, Waern M, Blennow K, Pálsson S, Rosengren L, Gustafson D.

Am J Geriatr Psychiatry. 2007 Oct;15(10):832-8.

PMID:
17911361
3.

Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis.

Axelsson M, Malmeström C, Nilsson S, Haghighi S, Rosengren L, Lycke J.

J Neurol. 2011 May;258(5):882-8. doi: 10.1007/s00415-010-5863-2. Epub 2011 Jan 1.

PMID:
21197541
4.

Neurofilament and glial fibrillary acidic protein in multiple sclerosis.

Norgren N, Sundström P, Svenningsson A, Rosengren L, Stigbrand T, Gunnarsson M.

Neurology. 2004 Nov 9;63(9):1586-90.

PMID:
15534240
5.

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

Galasko D, Chang L, Motter R, Clark CM, Kaye J, Knopman D, Thomas R, Kholodenko D, Schenk D, Lieberburg I, Miller B, Green R, Basherad R, Kertiles L, Boss MA, Seubert P.

Arch Neurol. 1998 Jul;55(7):937-45.

PMID:
9678311
6.

Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.

Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttilä T.

Arch Neurol. 2009 Mar;66(3):382-9. doi: 10.1001/archneurol.2008.596.

PMID:
19273758
7.

Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults.

Stomrud E, Hansson O, Zetterberg H, Blennow K, Minthon L, Londos E.

Arch Neurol. 2010 Feb;67(2):217-23. doi: 10.1001/archneurol.2009.316.

PMID:
20142530
8.

CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus.

Agren-Wilsson A, Lekman A, Sjöberg W, Rosengren L, Blennow K, Bergenheim AT, Malm J.

Acta Neurol Scand. 2007 Nov;116(5):333-9.

PMID:
17922727
9.

CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer's disease and controls.

Pijnenburg YA, Janssen JC, Schoonenboom NS, Petzold A, Mulder C, Stigbrand T, Norgren N, Heijst H, Hack CE, Scheltens P, Teunissen CE.

Dement Geriatr Cogn Disord. 2007;23(4):225-30. Epub 2007 Feb 9.

PMID:
17290105
10.

CSF neurofilament proteins levels are elevated in sporadic Creutzfeldt-Jakob disease.

van Eijk JJ, van Everbroeck B, Abdo WF, Kremer BP, Verbeek MM.

J Alzheimers Dis. 2010;21(2):569-76. doi: 10.3233/JAD-2010-090649.

PMID:
20555148
11.
12.

Cerebrospinal fluid Abeta40 and Abeta42: natural course and clinical usefulness.

Shoji M.

Front Biosci. 2002 Apr 1;7:d997-1006. Review.

PMID:
11897565
13.

Biological data and clinical symptoms as predictors of astrogliosis and neurodegeneration in patients with second-stage Trypanosoma brucei gambiense sleeping sickness.

Lejon V, Legros D, Rosengren L, Gastellu Etchegorry M, Büscher P.

Am J Trop Med Hyg. 2001 Dec;65(6):931-5.

PMID:
11792001
14.

Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS.

Malmeström C, Haghighi S, Rosengren L, Andersen O, Lycke J.

Neurology. 2003 Dec 23;61(12):1720-5.

PMID:
14694036
15.

CSF neurofilament and glial fibrillary acidic protein in normal pressure hydrocephalus.

Tullberg M, Rosengren L, Blomsterwall E, Karlsson JE, Wikkelsö C.

Neurology. 1998 Apr;50(4):1122-7.

PMID:
9566405
16.
17.

Depression, antidepressants, and plasma amyloid beta (Beta) peptides in those elderly who do not have cardiovascular disease.

Sun X, Mwamburi DM, Bungay K, Prasad J, Yee J, Lin YM, Liu TC, Summergrad P, Folstein M, Qiu WQ.

Biol Psychiatry. 2007 Dec 15;62(12):1413-7. Epub 2007 Jun 4.

PMID:
17544381
18.

Serum amyloid beta protein in young and elderly depression: a pilot study.

Kita Y, Baba H, Maeshima H, Nakano Y, Suzuki T, Arai H.

Psychogeriatrics. 2009 Dec;9(4):180-5. doi: 10.1111/j.1479-8301.2009.00293.x.

19.

The longitudinal profile of CSF markers during external lumbar drainage.

Tarnaris A, Toma AK, Chapman MD, Petzold A, Kitchen ND, Keir G, Watkins LD.

J Neurol Neurosurg Psychiatry. 2009 Oct;80(10):1130-3. doi: 10.1136/jnnp.2008.171686. Epub 2009 Jun 16.

PMID:
19535354
20.

Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease.

Mulder C, Verwey NA, van der Flier WM, Bouwman FH, Kok A, van Elk EJ, Scheltens P, Blankenstein MA.

Clin Chem. 2010 Feb;56(2):248-53. doi: 10.1373/clinchem.2009.130518. Epub 2009 Oct 15.

Supplemental Content

Support Center